SQZ Biotechnologies Company SQZB
0.02 USD 0.00 (+0.00%)
At closeFeb 5, 2026, 4:00 PM EST
0.023 Day range 0.023
0.01 52-week range 0.05
- YTD
- 0.00%
- 1 year
- +4.35%
News
defenseworld.net SQZ Biotechnologies Company (OTCMKTS:SQZB) Sees Large Drop in Short Interest SQZ Biotechnologies Company (OTCMKTS:SQZB - Get Free Report) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 6,479…
businesswire.com STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based…
businesswire.com Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (OTC: SQZB) (the “Company” or “SQZ”) today announced the results for the proposals considered and voted upon by its shareholders at its…
businesswire.com SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates WATERTOWN, Mass.WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, today reported third quarter 2023 financial…
businesswire.com SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, presented clinical data for three programs focused on the…
businesswire.com SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, today reported second quarter 2023 financial results and recent…
